$17.98
-0.49 (-2.65%)
Alkermes, Inc. (NASDAQ:ALKS)
CAPS Rating:
A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.
RSS Headlines
Fool UK